Characterization of a mouse model of leptomeningeal melanocytic disease.

被引:0
|
作者
Gonzalez, Israel Castillo [1 ]
Freitas, Juliano [2 ]
Li, Xiaoshuang [1 ]
Cavallini, Martina [1 ]
Kos, Lidia [1 ]
机构
[1] Florida Int Univ, Miami, FL 33199 USA
[2] Univ Miami, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2916
引用
收藏
页数:1
相关论文
共 50 条
  • [31] THE EFFECT OF EXERCISE ON THE MICROVASCULATURE OF THE SENSORIMOTOR CORTEX IN A MOUSE MODEL OF ALZHEIMER'S DISEASE.
    Thomason, L. A. M.
    Maliszewska-Cyna, E.
    Dorr, A.
    Steinman, J.
    Sled, J. G.
    Aubert, I.
    Stefanovic, B.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 199 - 200
  • [32] A homozygous alpha-knockout of a transgenic mouse model for sickle cell disease.
    Fabry, ME
    Paszty, C
    Costantini, F
    Rubin, EM
    Nagel, RL
    BLOOD, 1996, 88 (10) : 2471 - 2471
  • [33] Using mouse ENU mutagenesis to define gene function and model human disease.
    Justice, Monica J.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1701 - 1701
  • [34] Alveolar macrophages regulate granulomatous inflammation in a mouse model of chronic beryllium disease.
    McKee, Amy
    Mack, Douglas
    Fontenot, Andrew
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [35] Hypercholesterolemia accelerates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Refolo, L
    Duff, K
    Malester, B
    LaFrancois, J
    Wang, R
    Sambamurti, K
    Tint, GS
    Thomas, T
    Pappolla, MA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 424 - 424
  • [36] New GvHD mouse model for assessing both acute and chronic phase of the disease.
    Wiecha, Oktawiusz
    Miezynski, Witold
    Wojakiewicz, Leszek
    Zebzda, Anna
    Wedrychowicz, Anna
    Gozdzik, Jolanta
    Majka, Marcin
    BLOOD, 2006, 108 (11) : 382B - 382B
  • [37] Thrombospondin 4 reduces amyloid deposition in a mouse model of Alzheimer's disease.
    Maillet, M.
    Molkentin, J. D.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [38] Evidence of reperfusion injury physiology in a transgenic mouse model of sickle cell disease.
    Osarogiagbon, R
    Choong, S
    Patton, M
    Sheng, K
    Belcher, J
    Vercellotti, G
    Paller, M
    Hebbel, RP
    BLOOD, 1997, 90 (10) : 2687 - 2687
  • [39] Region specific changes of gene expression in a transgenic mouse model for Huntington disease.
    Oyama, F
    Miyazaki, H
    Sakamoto, N
    Jana, NR
    Kotliarova, SE
    Nukina, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 544 - 544
  • [40] Intraventricular application of rituximab as a treatment option in patients with CNS lymphoma and leptomeningeal disease.
    Schulz, H
    Pels, H
    Schlegel, U
    Zeelen, U
    Germing, U
    Engert, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 112S - 112S